Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miso Park

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Immunity|November 12, 2022
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopesChengcheng Fan, Alexander A Cohen, Miso Park, et al.
Journal of Hematology & Oncology|November 12, 2025
MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemiaKaito Harada, Dandan Zhao, Miso Park, et al.
Cell Reports|June 20, 2024
Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skinJeong-Eun Lee, Mina Kim, Sotaro Ochiai, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancerKurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemiaMariam Murtadha, Miso Park, Yinghui Zhu, et al.
Signal Transduction and Targeted Therapy|May 6, 2026
ADAMTS4 elicits myeloid-derived immune cell recruitment and liver fibrogenesis in metabolic dysfunction-associated steatotic liver diseaseJeongwoo Park, Taeeung Kim, Wan Seob Shim, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T CellsCheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Cancer Research|April 29, 2021
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and ChemoresistanceMiso Park, Ji Won Kim, Kyu Min Kim, et al.
Blood|February 23, 2024
A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expressionMariam Murtadha, Miso Park, Yinghui Zhu, et al.
Journal of Hematology & Oncology|August 14, 2024
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cellsYi Zhang, Miso Park, Lucy Y Ghoda, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Immunity|November 12, 2022
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopesChengcheng Fan, Alexander A Cohen, Miso Park, et al.
Journal of Hematology & Oncology|November 12, 2025
MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemiaKaito Harada, Dandan Zhao, Miso Park, et al.
Cell Reports|June 20, 2024
Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skinJeong-Eun Lee, Mina Kim, Sotaro Ochiai, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancerKurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemiaMariam Murtadha, Miso Park, Yinghui Zhu, et al.
Signal Transduction and Targeted Therapy|May 6, 2026
ADAMTS4 elicits myeloid-derived immune cell recruitment and liver fibrogenesis in metabolic dysfunction-associated steatotic liver diseaseJeongwoo Park, Taeeung Kim, Wan Seob Shim, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T CellsCheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Cancer Research|April 29, 2021
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and ChemoresistanceMiso Park, Ji Won Kim, Kyu Min Kim, et al.
Blood|February 23, 2024
A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expressionMariam Murtadha, Miso Park, Yinghui Zhu, et al.
Journal of Hematology & Oncology|August 14, 2024
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cellsYi Zhang, Miso Park, Lucy Y Ghoda, et al.
Pageof 5